Table of Contents Author Guidelines Submit a Manuscript
Journal of Obesity
Volume 2011, Article ID 984245, 9 pages
http://dx.doi.org/10.1155/2011/984245
Review Article

Weight Considerations in Pharmacotherapy for Type 2 Diabetes

Department of Endocrinology, Diabetes, and Metabolism, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA

Received 15 June 2010; Accepted 26 July 2010

Academic Editor: A. Halpern

Copyright © 2011 Vicky Cheng and Sangeeta R. Kashyap. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [9 citations]

The following is the list of published articles that have cited the current article.

  • Stacy L. Meyer, and Robert P. Hoffman, “Retrospective chart review of children with type 2 diabetes mellitus evaluating the efficacy of metformin vs. insulin vs. Combination insulin/metformin,” Southern Medical Journal, vol. 104, no. 10, pp. 684–688, 2011. View at Publisher · View at Google Scholar
  • Alberto Corsini, and Roberta Baetta, “Pharmacology of Dipeptidyl Peptidase-4 Inhibitors Similarities and Differences,” Drugs, vol. 71, no. 11, pp. 1441–1467, 2011. View at Publisher · View at Google Scholar
  • Harry G. Preuss, Bobby Echard, Jia Fu, Nicholas V. Perricone, Debasis Bagchi, Mark Kaylor, and Cun Zhuang, “Fraction SX of Maitake Mushroom Favorably Influences Blood Glucose Levels and Blood Pressure in Streptozotocin-Induced Diabetic Rats,” Journal of Medicinal Food, vol. 15, no. 10, pp. 901–908, 2012. View at Publisher · View at Google Scholar
  • V Pavlik, J. Fajfrova, L. Slovacek, and E. Drahokoupilova, “The role of sibutramine in weight reduction,” Bratislava Medical Journal-Bratislavske Lekarske Listy, vol. 114, no. 3, pp. 155–157, 2013. View at Publisher · View at Google Scholar
  • Donald Schumacher, “Pharmacological Management of the Obese Patient,” American Journal of Lifestyle Medicine, vol. 9, no. 2, pp. 137–156, 2015. View at Publisher · View at Google Scholar
  • Robin P. Blackstone, and Robin P. Blackstone, “Beyond Traditional Management: The Use of Medications in the Treatment of Obesity,” Obesity, pp. 231–260, 2016. View at Publisher · View at Google Scholar
  • Nadia M.S. Arafa, Mohamed-Assem S. Marie, and Sara Abdullah Mubarak AlAzimi, “Effect of canagliflozin and metformin on cortical neurotransmitters in a diabetic rat model,” Chemico-Biological Interactions, 2016. View at Publisher · View at Google Scholar
  • Vanita R. Aroda, Matthew S. Capehorn, Louis Chaykin, Juan P. Frias, Nanna L. Lausvig, Stanislava Macura, Jörg Lüdemann, Sten Madsbad, Julio Rosenstock, Omur Tabak, Sayeh Tadayon, and Stephen C. Bain, “Impact of baseline characteristics and beta‐cell function on the efficacy and safety of subcutaneous once‐weekly semaglutide: A patient‐level, pooled analysis of the SUSTAIN 1‐5 trials,” Diabetes, Obesity and Metabolism, 2019. View at Publisher · View at Google Scholar
  • YasserA Albarkah, AylaM Tourkmani, AbdulazizM Bin Rsheed, TurkiJ Al Harbi, YasserA Ebeid, and ReuofA Bushnag, “Effects of liraglutide addition to multiple diabetes regimens on weight and risk of hypoglycemia for a cohort with type 2 diabetes followed in primary care clinics in Saudi Arabia,” Journal of Family Medicine and Primary Care, vol. 8, no. 6, pp. 1919, 2019. View at Publisher · View at Google Scholar